vs
Side-by-side financial comparison of INTERGROUP CORP (INTG) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
LIFECORE BIOMEDICAL, INC. \DE\ is the larger business by last-quarter revenue ($31.1M vs $17.3M, roughly 1.8× INTERGROUP CORP). INTERGROUP CORP runs the higher net margin — 8.8% vs -32.1%, a 40.9% gap on every dollar of revenue. On growth, INTERGROUP CORP posted the faster year-over-year revenue change (19.8% vs -4.5%). LIFECORE BIOMEDICAL, INC. \DE\ produced more free cash flow last quarter ($25.0K vs $-481.0K). Over the past eight quarters, INTERGROUP CORP's revenue compounded faster (7.8% CAGR vs -0.1%).
Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
INTG vs LFCR — Head-to-Head
Income Statement — Q2 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $17.3M | $31.1M |
| Net Profit | $1.5M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | 11.6% | -9.9% |
| Net Margin | 8.8% | -32.1% |
| Revenue YoY | 19.8% | -4.5% |
| Net Profit YoY | 155.6% | -52.0% |
| EPS (diluted) | $0.71 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $17.3M | — | ||
| Q3 25 | $17.9M | $31.1M | ||
| Q2 25 | $16.2M | — | ||
| Q1 25 | $16.8M | $35.2M | ||
| Q4 24 | $14.4M | $32.6M | ||
| Q3 24 | $16.9M | $24.7M | ||
| Q2 24 | $13.4M | — | ||
| Q1 24 | $14.9M | $35.7M |
| Q4 25 | $1.5M | — | ||
| Q3 25 | $-535.0K | $-10.0M | ||
| Q2 25 | $-2.2M | — | ||
| Q1 25 | $-578.0K | $-14.8M | ||
| Q4 24 | $-2.7M | $-6.6M | ||
| Q3 24 | $-398.0K | $-16.2M | ||
| Q2 24 | $-4.9M | — | ||
| Q1 24 | $-3.2M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | 11.6% | — | ||
| Q3 25 | 15.3% | -9.9% | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 14.0% | -25.7% | ||
| Q4 24 | 5.9% | -6.0% | ||
| Q3 24 | 18.5% | -46.9% | ||
| Q2 24 | 3.7% | — | ||
| Q1 24 | 4.8% | -2.5% |
| Q4 25 | 8.8% | — | ||
| Q3 25 | -3.0% | -32.1% | ||
| Q2 25 | -13.9% | — | ||
| Q1 25 | -3.4% | -42.0% | ||
| Q4 24 | -18.9% | -20.2% | ||
| Q3 24 | -2.4% | -65.7% | ||
| Q2 24 | -36.7% | — | ||
| Q1 24 | -21.3% | 43.8% |
| Q4 25 | $0.71 | — | ||
| Q3 25 | $-0.25 | $-0.29 | ||
| Q2 25 | — | — | ||
| Q1 25 | $-0.27 | $-0.47 | ||
| Q4 24 | $-1.26 | $-0.25 | ||
| Q3 24 | $-0.18 | $-0.53 | ||
| Q2 24 | — | — | ||
| Q1 24 | $-1.44 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.5M | $18.9M |
| Total DebtLower is stronger | $233.2M | $136.0M |
| Stockholders' EquityBook value | $-85.2M | $-10.5M |
| Total Assets | $101.1M | $235.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.5M | — | ||
| Q3 25 | $6.0M | $18.9M | ||
| Q2 25 | $6.1M | — | ||
| Q1 25 | $4.8M | $5.4M | ||
| Q4 24 | $15.4M | $9.5M | ||
| Q3 24 | $12.2M | — | ||
| Q2 24 | $11.6M | — | ||
| Q1 24 | $19.5M | — |
| Q4 25 | $233.2M | — | ||
| Q3 25 | $237.8M | $136.0M | ||
| Q2 25 | $240.5M | — | ||
| Q1 25 | $241.5M | $124.9M | ||
| Q4 24 | $227.2M | $111.3M | ||
| Q3 24 | $218.1M | $106.3M | ||
| Q2 24 | $225.7M | — | ||
| Q1 24 | $225.0M | $97.1M |
| Q4 25 | $-85.2M | — | ||
| Q3 25 | $-86.7M | $-10.5M | ||
| Q2 25 | $-86.1M | — | ||
| Q1 25 | $-84.5M | $2.2M | ||
| Q4 24 | $-83.9M | $15.4M | ||
| Q3 24 | $-80.9M | $-3.9M | ||
| Q2 24 | $-80.3M | — | ||
| Q1 24 | $-76.4M | $17.7M |
| Q4 25 | $101.1M | — | ||
| Q3 25 | $102.5M | $235.2M | ||
| Q2 25 | $104.1M | — | ||
| Q1 25 | $103.2M | $237.7M | ||
| Q4 24 | $110.6M | $255.4M | ||
| Q3 24 | $109.3M | $246.8M | ||
| Q2 24 | $107.8M | — | ||
| Q1 24 | $119.0M | $246.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 56.05× | ||
| Q4 24 | — | 7.20× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-23.0K | $1.8M |
| Free Cash FlowOCF − Capex | $-481.0K | $25.0K |
| FCF MarginFCF / Revenue | -2.8% | 0.1% |
| Capex IntensityCapex / Revenue | 2.6% | 5.6% |
| Cash ConversionOCF / Net Profit | -0.02× | — |
| TTM Free Cash FlowTrailing 4 quarters | $739.0K | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-23.0K | — | ||
| Q3 25 | $-296.0K | $1.8M | ||
| Q2 25 | $5.9M | — | ||
| Q1 25 | $-854.0K | $1.2M | ||
| Q4 24 | $-781.0K | $-6.1M | ||
| Q3 24 | $3.4M | $-613.0K | ||
| Q2 24 | $6.8M | — | ||
| Q1 24 | $1.9M | $-1.4M |
| Q4 25 | $-481.0K | — | ||
| Q3 25 | $-1.3M | $25.0K | ||
| Q2 25 | $3.6M | — | ||
| Q1 25 | $-1.2M | $-4.3M | ||
| Q4 24 | $-1.1M | $-8.6M | ||
| Q3 24 | $3.1M | $-4.0M | ||
| Q2 24 | $2.7M | — | ||
| Q1 24 | $1.1M | $-7.8M |
| Q4 25 | -2.8% | — | ||
| Q3 25 | -7.1% | 0.1% | ||
| Q2 25 | 22.5% | — | ||
| Q1 25 | -6.8% | -12.1% | ||
| Q4 24 | -7.8% | -26.3% | ||
| Q3 24 | 18.3% | -16.3% | ||
| Q2 24 | 20.4% | — | ||
| Q1 24 | 7.6% | -21.8% |
| Q4 25 | 2.6% | — | ||
| Q3 25 | 5.4% | 5.6% | ||
| Q2 25 | 13.9% | — | ||
| Q1 25 | 1.8% | 15.5% | ||
| Q4 24 | 2.4% | 7.5% | ||
| Q3 24 | 1.6% | 13.9% | ||
| Q2 24 | 30.4% | — | ||
| Q1 24 | 4.9% | 17.8% |
| Q4 25 | -0.02× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
